Boston Massachusetts based Life Biosciences is raising $99,999,997.00 in New Equity Investment.
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Life Biosciences is raising $99,999,997.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Tristan Edwards played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Life Biosciences
Life Biosciences is a leader in developing and commercializing science that extends the healthy human lifespan. As a species, we live longer than ever but not much better. Uniquely, we focus on the underlying biology of aging. This means our therapies each have the potential to address multiple age related diseases that impact longevity far upstream from conventional medicine. Life Biosciences focuses on the condition of aging and its consequences to address this crisis and market which recent viral epidemics have shown require better disease therapies, especially among the elderly, one of our most at-risk populations.
To learn more about Life Biosciences, visit http://lifebiosciences.com/
Contact:
Tristan Edwards, Chief Executive Officer
857-400-9245
tristan@lifebiosciences.com
https://www.linkedin.com/in/atristanedwards/
SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved